跳至主要内容
临床试验/NL-OMON51500
NL-OMON51500招募中不适用

Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus minimally invasive esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT-2 trial). - ROBOT-2

niversity Medical Center Mainz0 个研究点目标入组 109 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
109

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Histologically proven squamous cell carcinoma, adenocarcinoma or
  • undifferentiated carcinoma of the intrathoracic esophagus (including Siewert I
  • - Surgically resectable (T1-4a, N0-3, M0)
  • - Age >= 18 and <= 90 years
  • - European Clinical Oncology Group (ECOG) performance status 0,1 or 2
  • - Written informed consent

排除标准

  • - Carcinoma of the cervical esophagus
  • - Carcinoma of the gastro-esophageal junction (GEJ) with the main part of the
  • tumor in the gastric cardia (Siewert type III)
  • - Prior thoracic surgery at the right hemithorax or thoracic trauma

研究者

发起方
niversity Medical Center Mainz

相似试验

Robot-assisted minimally invasive... | 临床试验